Samsung Electronics has received approval from the United States Food and Drug Administration (FDA) to introduce a sleep apnea detection system in its ‘smartwatch’, the Galaxy Watch, which can be consulted through a health application.
This feature allows users over the age of 22 who have not been diagnosed with obstructive sleep apnea (OSA) to determine if they have it during a given follow-up period. Specifically, the quality of sleep will be known over a period of ten days.
OSA causes a person to stop breathing while sleeping, which hinders oxygen delivery, reduces sleep quality and increases daytime fatigue. It may increase the risk of heart diseases, including high blood pressure or cardiac arrhythmias.
The South Korean technology company has announced that it plans to introduce monitoring tools for this respiratory disorder in its watches in the third quarter of this year, a functionality that can be accessed from the Samsung Health Monitor application.
The firm acknowledged in a statement that it hopes the new function, which has already received approval from the FDA after approval from Korea’s Ministry of Food and Drug Safety (MFDS), “will help more people actively seek treatment for severe or critical “Can help detect disease”. “Moderate cases of OSA.”
This functionality will first reach the Galaxy Watch series in the United States, and will later be expanded to the rest of the countries and regions where Galaxy Watch watches are sold.